Implementing the 2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure: SGLT2 Inhibitors, Treatment Sequencing, and Value Statements
A Q&A With Paul Heidenreich, MD
A Q&A With Milton Packer, MD
A Q&A With Gary Besinque, PharmD
Advertisement
Advertisement
Trending on AJMC
1
Flow Cytometry Tracks CAR T-Cell Therapy Persistence in Aggressive LBCL
2
Newly Identified RTEL1 Variant Could Broaden Genetic Landscape of Familial PF
3
Inside the VA’s Hub-and-Spoke Model for Multiple Sclerosis Care: Rebecca Spain, MD
4
2025 Hypertension Guideline Updates Presented at AHA Scientific Sessions
5
